Sequent Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Sequent Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sequent Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Sequent Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SEQUENT total liabilities for a breakdown of total debt and financial obligations.

Sequent Scientific Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sequent Scientific Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Brainsway Ltd NASDAQ:BWAY	-0.010x
mF International Limited Ordinary Shares NASDAQ:MFI	-0.118x
V-Mart Retail Limited NSE:VMART	0.008x
Kaveri Seed Company Limited NSE:KSCL	-0.083x
Zhejiang Dibay Electric Co Ltd SHG:603320	0.023x
ADENTRA INC. F:UQ0	N/A
Suli Co Ltd SHG:603585	0.075x
Shanghai Yahong Moulding Co Ltd SHG:603159	0.055x

Annual Cash Flow Conversion Efficiency for Sequent Scientific Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Sequent Scientific Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Sequent Scientific Limited (SEQUENT) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs7.70 Billion ≈ $83.31 Million	Rs833.60 Million ≈ $9.02 Million	0.108x	+152.16%
2024-03-31	Rs7.13 Billion ≈ $77.10 Million	Rs305.95 Million ≈ $3.31 Million	0.043x	+91.28%
2023-03-31	Rs7.49 Billion ≈ $81.02 Million	Rs168.08 Million ≈ $1.82 Million	0.022x	-45.73%
2022-03-31	Rs7.40 Billion ≈ $80.04 Million	Rs305.95 Million ≈ $3.31 Million	0.041x	-72.03%
2021-03-31	Rs7.76 Billion ≈ $83.96 Million	Rs1.15 Billion ≈ $12.41 Million	0.148x	-6.20%
2020-03-31	Rs7.32 Billion ≈ $79.15 Million	Rs1.15 Billion ≈ $12.47 Million	0.158x	+1.45%
2019-03-31	Rs7.47 Billion ≈ $80.78 Million	Rs1.16 Billion ≈ $12.55 Million	0.155x	+135.05%
2018-03-31	Rs6.85 Billion ≈ $74.03 Million	Rs452.39 Million ≈ $4.89 Million	0.066x	+1013.61%
2017-03-31	Rs9.94 Billion ≈ $107.50 Million	Rs-71.90 Million ≈ $-777.57K	-0.007x	-12597.48%
2016-03-31	Rs9.48 Billion ≈ $102.51 Million	Rs-540.00K ≈ $-5.84K	0.000x	+99.94%
2015-03-31	Rs2.38 Billion ≈ $25.76 Million	Rs-235.49 Million ≈ $-2.55 Million	-0.099x	+86.47%
2014-03-31	Rs613.06 Million ≈ $6.63 Million	Rs-447.85 Million ≈ $-4.84 Million	-0.731x	-1803.87%
2013-03-31	Rs995.83 Million ≈ $10.77 Million	Rs-38.21 Million ≈ $-413.23K	-0.038x	-116.25%
2012-03-31	Rs1.28 Billion ≈ $13.84 Million	Rs302.36 Million ≈ $3.27 Million	0.236x	-37.08%
2011-03-31	Rs1.35 Billion ≈ $14.60 Million	Rs506.60 Million ≈ $5.48 Million	0.375x	+148.36%
2010-03-31	Rs1.12 Billion ≈ $12.09 Million	Rs168.95 Million ≈ $1.83 Million	0.151x	+223.00%
2009-03-31	Rs405.20 Million ≈ $4.38 Million	Rs-49.79 Million ≈ $-538.46K	-0.123x	-14561.60%
2008-03-31	Rs573.71 Million ≈ $6.20 Million	Rs487.47K ≈ $5.27K	0.001x	-99.26%
2007-03-31	Rs349.24 Million ≈ $3.78 Million	Rs40.21 Million ≈ $434.91K	0.115x	-68.51%
2006-03-31	Rs198.08 Million ≈ $2.14 Million	Rs72.43 Million ≈ $783.26K	0.366x	--

About Sequent Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic

Market Cap

$529.07 Million

Rs48.92 Billion INR

Market Cap Rank

#12249 Global

#578 in India

Share Price

Rs193.72

Change (1 day)

-3.70%

52-Week Range

Rs152.68 - Rs252.00

All Time High

Rs322.89